MANCHESTER, United Kingdom & STAMFORD, Conn.--(BUSINESS WIRE)--Tepnel Life Sciences PLC (AIM: TED) today announced that it has expanded its molecular genetic services offering through the addition of Illumina’s iScan System, a next-generation scanner that provides researchers conducting genetic variation studies with significantly greater throughput and application diversity. This announcement marks the first anniversary of Tepnel’s new pharmaceutical services facility and makes Tepnel the first commercial provider of iScan services within the UK.